FundingWatcher
Home / Startups / By venture fund / Alexandria Venture Investments portfolio companies

Alexandria Venture Investments portfolio companies

Updated 16 Nov 2026

http://www.are.com/venture-investments.html

Alexandria Venture Investments portfolio companies
One-time CSV
  • 28 funded companies, 28 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-alexandria-venture-investments.csv28 rows × 18 columns
CompanyCityLast roundAmountDate
TwoStep TherapeuticsPalo AltoSeries A$62.5M2026-09-09
Lycia TherapeuticsSouth San FranciscoSeries D$75.0M2026-06-25
InariCambridgeSeries G$144.0M2025-01-07
Triveni BioWatertownSeries C$65.0M2026-06-17
InsitroSouth San FranciscoSeries C$400.0M2021-03-15
ImmunaiNew YorkSeries B$215.0M2021-10-27
Capstan TherapeuticsSan DiegoSeries B$175.0M2024-03-20
Aspen NeuroscienceSan DiegoSeries C$115.0M2025-11-20

8 rows of the CSV in 5 of its 18 columns.

28
Startups
$5.3B
Total raised
5
Funded in the last 12 months
$319.1M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

17 of 28
17 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto, United States Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco, United States Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Cambridge, United States Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego, United States Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
TORL BioTherapeutics TORL BioTherapeutics is a clinical-stage biopharmaceutical company developing new therapies. Biotech Culver City, United States Series C $96.0M 2025-10-07 $412.0M Goldman Sachs, RA Capital Management, Alexandria Venture Investments +2 51 to 100 2018
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Cambridge, United States Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
Avalo Avalo applies AI and evolutionary methods to plant biotechnology for a more sustainable food system. Artificial intelligence Durham, United States Series A $11.0M 2025-03-06 $14.9M SOSV, SOSV SF & NY (Fka IndieBio), Alexandria Venture Investments +2 11 to 50 2020
Inari Unicorn Inari is a seed design and biotechnology company developing seeds for a nature-positive food system. Biotech Cambridge, United States Series G $144.0M 2025-01-07 $753.0M EDBI, Alexandria Venture Investments, CPP Investments +2 251 to 500 2016
Valora Therapeutics Valora Therapeutics engineers chimeric antibodies as a biotechnology company. Biotech La Jolla, United States Seed $30.0M 2024-11-20 $30.0M Correlation Ventures, Alexandria Venture Investments, TigerGene +2 11 to 50 2023
Delphia Therapeutics Delphia Therapeutics operates a laboratory that develops treatments for cancer cells. Health care Cambridge, United States Series A $67.0M 2024-05-02 $67.0M Google Ventures, Polaris Partners, Alexandria Venture Investments +1 11 to 50 2022
Capstan Therapeutics Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases. Biotech San Diego, United States Series B $175.0M 2024-03-20 $340.0M RA Capital Management, OrbiMed, Alexandria Venture Investments +2 101 to 250 2021
Elo Life Systems Elo Life Systems is a biotechnology company that studies how food supports human health and wellness. Biotech Durham, United States Series A $20.5M 2024-01-24 $56.5M Novo Holdings, Alexandria Venture Investments, DCVC Bio +2 11 to 50 2006
Tome Biosciences Tome Biosciences develops programmable gene insertion technology. Biotech Watertown, United States Series A $213.0M 2023-12-12 $213.0M Andreessen Horowitz, Google Ventures, Polaris Partners +1 101 to 250 2021
ROME Therapeutics ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. Biotech Cambridge, United States Series B $72.0M 2023-09-12 $199.0M Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 11 to 50 2020
Immunai Unicorn Immunai applies machine learning and software engineering to map and reprogram immunology. Artificial intelligence New York, United States Series B $215.0M 2021-10-27 $295.0M 8VC, TLV Partners, Alexandria Venture Investments +2 101 to 250 2018
Insitro Unicorn Insitro applies machine learning and biology to drug discovery and development. Artificial intelligence South San Francisco, United States Series C $400.0M 2021-03-15 $643.0M Temasek, BlackRock, ARCH Venture Partners +1 251 to 500 2018

Table 1. Alexandria Venture Investments portfolio companies: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 28.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego, United States Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
2 Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco, United States Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
3 Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
4 TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto, United States Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
5 Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Cambridge, United States Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 2. Alexandria Venture Investments portfolio companies: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Google Ventures Corporate venture arm San Francisco, United States 5 18% 1 Aspen Neuroscience
2 OrbiMed Private equity firm New York, United States 4 14% 2 Triveni Bio, Aspen Neuroscience
3 Bristol-Myers Squibb Venture capital firm New York, United States 4 14%
4 Polaris Partners Private equity firm Boston, United States 3 11% 1 Triveni Bio
5 ARCH Venture Partners Venture capital firm Chicago, United States 3 11%
6 RA Capital Management Startup incubator Boston, United States 3 11%
7 Andreessen Horowitz Venture capital firm Menlo Park, United States 3 11%
8 Invus Private equity firm New York, United States 2 7% 2 Lycia Therapeutics, Triveni Bio
9 Blue Owl Private equity firm New York, United States 2 7% 1 Lycia Therapeutics
10 EDBI Venture capital firm Singapore 2 7% 1 Aspen Neuroscience
11 Catalio Capital Management Venture capital firm New York, United States 2 7%
12 S32 Venture capital firm San Diego, United States 2 7% 1 Aspen Neuroscience
13 Casdin Capital Venture capital firm New York, United States 2 7%
14 NFX Startup accelerator San Francisco, United States 1 4% 1 TwoStep Therapeutics
15 2048 Ventures Venture capital firm New York, United States 1 4% 1 TwoStep Therapeutics

Table 3. Alexandria Venture Investments portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 27 96% $5.2B
Health care 23 82% $4.5B
Software 9 32% $1.4B
Artificial intelligence 7 25% $1.4B
Hardware 1 4% $7.0M

Table 4. Alexandria Venture Investments portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 3 11% $18.0M
Series A 10 36% $35.0M
Series B 8 29% $144.0M
Series C 5 18% $115.0M
Series D+ 2 7% $144.0M

Table 5. Alexandria Venture Investments portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 25 89%
Canada 3 11%

Table 6. Alexandria Venture Investments portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Cambridge 6 21%
San Diego 3 11%
Seattle 3 11%
South San Francisco 2 7%
Watertown 2 7%
New York 2 7%
Durham 2 7%
Toronto 2 7%
Palo Alto 1 4%
Culver City 1 4%
La Jolla 1 4%
San Francisco 1 4%

Table 7. Alexandria Venture Investments portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 20% $62.5M
June 2026 2 40% $140.0M
April 2026 1 20% $1.6M
November 2025 1 20% $115.0M

Table 8. Alexandria Venture Investments portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 14% $204.1M
2025 5 18% $521.0M
2024 9 32% $639.5M
2023 4 14% $320.0M
2022 1 4% $26.0M
2021 4 14% $805.0M

Table 9. Alexandria Venture Investments portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 4 14%
2020 to 2022 10 36%
2015 to 2019 11 39%
2010 to 2014 2 7%
Before 2010 1 4%

Table 10. Alexandria Venture Investments portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 3 11%
11 to 50 15 54%
51 to 100 3 11%
101 to 250 5 18%
251 to 500 2 7%

Table 11. Alexandria Venture Investments portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many Alexandria Venture Investments portfolio companies are on the list?
28, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 28 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Alexandria Venture Investments portfolio companies: 28 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 28 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/alexandria-venture-investments/